Page last updated: 2024-11-05

zolpidem and Lewy Body Disease

zolpidem has been researched along with Lewy Body Disease in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kobayashi, R1
Morioka, D1
Suzuki, A1
Kawakatsu, S1
Otani, K1

Other Studies

1 other study available for zolpidem and Lewy Body Disease

ArticleYear
Low-dose zolpidem-induced visual hallucinations in prodromal dementia with Lewy bodies.
    Asian journal of psychiatry, 2021, Volume: 66

    Topics: Alzheimer Disease; Hallucinations; Humans; Lewy Body Disease; Prodromal Symptoms; Zolpidem

2021